How Vivaldi Built KCI Healthcare’s Unified Global Wound Care Brand

Healthcare

The Challenge

KCI Healthcare had a strong innovation track record in wound care, yet its brand presence lacked cohesion and clarity across global markets. Fragmented messaging and inconsistent identity were limiting awareness and clinician trust.

The Opportunity

Vivaldi diagnosed the brand fragmentation, identified root causes, and created a unified, premium brand identity aligning global teams and resonating with clinicians. The work included brand architecture, positioning, organizational alignment, and marketing activation.

The Outcome

KCI launched a compelling global brand architecture with unified messaging, improving awareness and trust among clinicians worldwide. The engagement gave KCI a durable platform for consistent brand-building across its wound care portfolio.

KCI Healthcare Case Study Summary

KCI Healthcare engaged Vivaldi to resolve brand fragmentation across global markets that was limiting awareness and clinician trust despite a strong innovation track record in wound care, anchored by the V.A.C. Therapy system. Vivaldi diagnosed the root causes of the fragmentation, built a unified premium brand architecture, and aligned global teams behind positioning that resonated with clinicians, giving KCI a durable platform for brand-building across its wound care portfolio.

About KCI Healthcare

KCI (Kinetic Concepts, Inc.) is a global medical device company specializing in advanced wound care and therapeutic support surfaces, including the market-leading V.A.C. Therapy negative-pressure wound therapy system. Historically headquartered in San Antonio, Texas, KCI was acquired by 3M and is now part of Solventum’s medical business.

Frequently Asked Questions

What did Vivaldi help KCI Healthcare achieve with the global brand work?

Vivaldi delivered a unified global brand architecture, positioning, and messaging system that aligned KCI’s regional teams and improved awareness and clinician trust. The work gave KCI’s wound care portfolio a consistent platform across markets, rather than the patchwork of identities that had limited the brand despite the strength of the underlying products.

How did Vivaldi diagnose the root causes of the brand fragmentation?

Rather than start from a visual refresh, the diagnosis traced how messaging, organizational structure, and regional autonomy had each contributed to the inconsistency, because brand fragmentation in a global medical device company is usually an organizational symptom not a creative one. Identifying the structural sources let the architecture be designed in a way regional teams could actually operate against.

Why does brand consistency matter for wound care products sold into clinicians?

Clinicians choose wound care based on a mix of clinical evidence, peer recommendation, and trust in the supplier, and inconsistent brand presence undermines the trust layer even when the evidence is strong. A unified architecture is what lets a wound care company’s clinical proof points compound across markets rather than be relitigated in every region.

What can other medical device companies take from the KCI approach?

The transferable lesson is that organizational alignment has to be designed into a brand architecture from day one, not bolted on afterward, because device companies with strong regional autonomy will revert to local interpretations within a year if the structure does not reward consistency. The architecture that holds is the one regional teams help build, not the one they receive.